These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22957374)

  • 1. [Control of doping. That is relevant for more than Olympic competitors].
    Bischoff M
    MMW Fortschr Med; 2012 Jul; 154(13):23. PubMed ID: 22957374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiology of doping in rural gyms in the district of Traunstein].
    Raschka C; Draßner N
    MMW Fortschr Med; 2015 Jul; 157 Suppl 5():5-8. PubMed ID: 26168742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance-enhancing substances in sports: a review of the literature.
    Momaya A; Fawal M; Estes R
    Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recreational athletes and doping--a survey in 11 gyms in the area of Frankfurt/Main].
    Raschka C; Chmiel C; Preiss R; Boos C
    MMW Fortschr Med; 2013 Aug; 155(14):57. PubMed ID: 24006599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recreational athletes and doping--a survey in 11 gyms in the area of Frankfurt/Main].
    Raschka C; Chmiel C; Preiss R; Boos C
    MMW Fortschr Med; 2013 Jul; 155 Suppl 2():41-3. PubMed ID: 24930320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doping in sport - attitude and professional experience among physicians in Poland.
    Domagała-Rodacka R; Rodacki T; Owczarek D; Cibor D; Zagrodzki P
    Folia Med Cracov; 2018; 58(3):35-47. PubMed ID: 30521510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping in East Germany: drugs as a geopolitical tool.
    Prescrire Int; 2016 Oct; 25(175):251. PubMed ID: 30645836
    [No Abstract]   [Full Text] [Related]  

  • 8. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stan Reents on Mike Bahrke's "Performance-enhancing substance misuse in sport: intervention programs". Testing for doping: pitfalls.
    Reents S
    Subst Use Misuse; 2012; 47(13-14):1521-2. PubMed ID: 23186458
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes.
    Dietz P; Ulrich R; Dalaker R; Striegel H; Franke AG; Lieb K; Simon P
    PLoS One; 2013; 8(11):e78702. PubMed ID: 24236038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance enhancing drugs in sports and the role of doctors: are there guidelines?
    Prakash K
    Indian J Med Ethics; 2013; 10(2):115-7. PubMed ID: 23697492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthony P. Millar on Michael Bahrke's Performance-enhancing substance misuse in sport: risk factors and considerations for intervention programs.
    Millar AP
    Subst Use Misuse; 2012; 47(13-14):1519-20. PubMed ID: 23186457
    [No Abstract]   [Full Text] [Related]  

  • 14. Azenildo Moura Santos on Michael Bahrke's "Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs".
    Santos AM
    Subst Use Misuse; 2012; 47(13-14):1517-8. PubMed ID: 23186456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Triathlon sport -- doping und brain doping--hand in hand?].
    Sportverletz Sportschaden; 2014 Mar; 28(1):4. PubMed ID: 24665011
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs.
    Bahrke MS
    Subst Use Misuse; 2012; 47(13-14):1505-16. PubMed ID: 23186455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tennis lesson: sharp practice in the science behind the Sharapova case.
    Arduini A; Zammit VA
    Postgrad Med J; 2016 Aug; 92(1090):429-30. PubMed ID: 27252310
    [No Abstract]   [Full Text] [Related]  

  • 19. Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
    Elliott S; Leishman B
    Bioanalysis; 2012 Jul; 4(13):1681-90. PubMed ID: 22831483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Faster, higher, stronger: knowledge about old and new doping substances].
    Pieters T; de Hon O
    Ned Tijdschr Geneeskd; 2013; 157(28):A6450. PubMed ID: 23841931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.